The Bulls N’ Bears ASX Runner of the Week is…biopharma minnow Zelira Therapeutics, which landed a US$33 million funding deal to fast-track its autism drug towards FDA approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback